SUPERNUS PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q1 2024.
  • Supernus Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $4M, a 15.8% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $12.9M, a 8.19% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $11.9M, a 71.4% increase from 2020.
  • Supernus Pharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $6.95M, a 30.2% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4M +$545K +15.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $3.46M +$508K +17.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $2.95M +$1.12M +60.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $1.83M +$573K +45.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $1.26M -$52K -3.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $1.31M -$72K -5.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $1.39M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.